Connection

PRAKASH MASAND to Clinical Trials as Topic

This is a "connection" page, showing publications PRAKASH MASAND has written about Clinical Trials as Topic.
Connection Strength

0.219
  1. Beyond serotonin: newer antidepressants in the future. Expert Rev Neurother. 2017 08; 17(8):777-790.
    View in: PubMed
    Score: 0.104
  2. The safety of SSRIs in generalised anxiety disorder: any reason to be anxious? Expert Opin Drug Saf. 2003 Sep; 2(5):485-93.
    View in: PubMed
    Score: 0.040
  3. Tolerability and adherence issues in antidepressant therapy. Clin Ther. 2003 Aug; 25(8):2289-304.
    View in: PubMed
    Score: 0.040
  4. Asenapine, blonanserin, iloperidone, lurasidone, and sertindole: distinctive clinical characteristics of 5 novel atypical antipsychotics. Clin Neuropharmacol. 2013 Nov-Dec; 36(6):223-38.
    View in: PubMed
    Score: 0.020
  5. Paroxetine: safety and tolerability issues. Expert Opin Drug Saf. 2008 Nov; 7(6):783-94.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.